Lower gastrointestinal bleeding CT scan: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:
==Overview==
==Overview==


==CT scan==
==Helical CT scan==
Helical CT scanning of the abdomen and pelvis is employed used when a routine workup fails to determine the cause of active gastrointestinal bleeding. Helical CT scanning is a safe, convenient, and an accurate diagnostic tool relative to mesenteric angiography and colonoscopy in diagnosing acute lower GI bleeding (LGIB). Findings of helical CT scan in lower gastrointestinal bleeding include:
Helical CT scanning of the abdomen and pelvis is employed used when a routine workup fails to determine the cause of active gastrointestinal bleeding. Helical CT scanning is a safe, convenient, and an accurate diagnostic tool relative to mesenteric angiography and colonoscopy in diagnosing acute lower GI bleeding (LGIB). Findings of helical CT scan in lower gastrointestinal bleeding include:
*Vascular extravasation of the contrast medium
*Vascular extravasation of the contrast medium
Line 25: Line 25:
|52.9%
|52.9%
|}
|}
==CT Angiography==
==CT Angiography==
*CTA is a multidetector CT scan performed in the arterial phase. Contrast (100 mL) is given via peripheral venous access and a CT scan is performed 30 seconds following injection. The scan is then repeated in the portal phase (70 seconds following injection)
*CTA is a multidetector CT scan performed in the arterial phase. Contrast (100 mL) is given via peripheral venous access and a CT scan is performed 30 seconds following injection. The scan is then repeated in the portal phase (70 seconds following injection)

Revision as of 16:16, 12 December 2017

Lower gastrointestinal bleeding Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lower gastrointestinal bleeding from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Management

Initial resuscitation
Pharmacotherapy

Surgery

Surgical Management
Endoscopic Intervention

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Lower gastrointestinal bleeding CT scan On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lower gastrointestinal bleeding CT scan

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lower gastrointestinal bleeding CT scan

CDC on Lower gastrointestinal bleeding CT scan

Lower gastrointestinal bleeding CT scan in the news

Blogs on Lower gastrointestinal bleeding CT scan

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Lower gastrointestinal bleeding CT scan

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Helical CT scan

Helical CT scanning of the abdomen and pelvis is employed used when a routine workup fails to determine the cause of active gastrointestinal bleeding. Helical CT scanning is a safe, convenient, and an accurate diagnostic tool relative to mesenteric angiography and colonoscopy in diagnosing acute lower GI bleeding (LGIB). Findings of helical CT scan in lower gastrointestinal bleeding include:

  • Vascular extravasation of the contrast medium
  • Contrast enhancement of the bowel wall
  • Thickening of the bowel wall
  • Spontaneous hyperdensity of the peri-bowel fat, and vascular dilatations.

Multidetector-row CT (MDCT) scanning is also useful in the evaluation of LGIB but its rarely used.

Sensitivity MDCT Endoscopy
Site 100%   88.2%
Etiology 52.9% 52.9%

CT Angiography

  • CTA is a multidetector CT scan performed in the arterial phase. Contrast (100 mL) is given via peripheral venous access and a CT scan is performed 30 seconds following injection. The scan is then repeated in the portal phase (70 seconds following injection)
  • CTA can detect bleeding with a rate of 0.5 mL/min or less whereas catheter angiography detects bleeding with a rate of 0.5 to 1 mL/min. Therefore, CTA is performed before catheter angiography.

Indications

  • In patients who are actively bleeding but who are relatively hemodynamically stable

Advantages

  • Noninvasive
  • CT Angiography can pick up findings in the solid organs and soft tissue structures that would not be seen on catheter angiography.
  • CT Angiography can potentially detect bleeding from any point in the gastrointestinal tract and may reveal an upper gastrointestinal source of bleeding in a patient thought to have LGIB.
  • CT Angiography can also help with planning embolization by revealing any iliac artery or mesenteric ostial atherosclerotic disease that may hamper access.
  • CTA also has the advantage that it is widely available 24 hours a day, unlike colonoscopy services in many areas.
  • If a patient then becomes unstable and an initial bleeding point is localized on CTA, then the choice has to be made between urgent colonoscopy, angiographic embolization, or surgery

Findings/Interpretation

  • Arterial phase CTA may show thrombus in the superior or inferior mesenteric artery.
  • CTA has a sensitivity of 93% to 100% and specificity of 100% in detecting mesenteric ischemia.
  • Advances made in CT with respect to greater resolution and shorter scanning times allow for improved identification of extravasated contrast material into the intestinal lumen
  • If CTA fails to show a source of bleeding, then catheter angiography is generally not performed.
  • If a bleeding point is seen on CTA, then catheter angiography and embolization can be undertaken

Disadvantage

  • Poor sensitivity

Contraindications

  • Contraindicated in patients with renal failure as the contrast agent may potentially worsen renal function.

References

Template:WH Template:WS